Eb5 Age Spot Treatment Cream Recalled for Stability Failures
Eb5 Corporation is recalling 4,632 tubes of Age Spot Treatment Cream because the product failed stability specifications for viscosity, pH, and specific gravity.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves failed stability specifications (viscosity, pH, specific gravity) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Eb5 Corporation is voluntarily recalling 4,632 tubes of eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. The product is packaged in a 177.4 ml / 6 fl oz carton containing a tube. The recall is limited to Batch B4276A with an expiration date of 03/2019.
The recall was initiated because the product failed stability specifications, specifically testing out-of-specification for viscosity, pH, and specific gravity. The product was distributed nationwide in the USA.
Consumers who have this specific batch of the product should stop using it and contact Eb5 Corporation for further instructions or a refund.
The recalled product
- Product
- eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. 177.4 ml / 6 fl oz carton containing a tube. Manufactured For: EB5 Corporation Portland, OR 97210 Carton Bar Code: 7 41099 00009 9
- Manufacturer
- Eb5 Corporation
- Category
- Drug — Topical Skin Lightening
- Affected units
- 4,632
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch B4276A EXP 03/2019
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24